WO2022075420A1 - ソフトウェア提供装置、ソフトウェア提供方法及びプログラム - Google Patents
ソフトウェア提供装置、ソフトウェア提供方法及びプログラム Download PDFInfo
- Publication number
- WO2022075420A1 WO2022075420A1 PCT/JP2021/037205 JP2021037205W WO2022075420A1 WO 2022075420 A1 WO2022075420 A1 WO 2022075420A1 JP 2021037205 W JP2021037205 W JP 2021037205W WO 2022075420 A1 WO2022075420 A1 WO 2022075420A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- software
- virtual machine
- data processing
- user group
- information
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 32
- 238000012545 processing Methods 0.000 claims abstract description 51
- 230000010365 information processing Effects 0.000 claims abstract description 17
- 102000048850 Neoplasm Genes Human genes 0.000 claims abstract description 15
- 108700019961 Neoplasm Genes Proteins 0.000 claims abstract description 8
- 108700020796 Oncogene Proteins 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 21
- 102000043276 Oncogene Human genes 0.000 claims description 12
- 206010028980 Neoplasm Diseases 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000004891 communication Methods 0.000 description 5
- 230000035772 mutation Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000008520 organization Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/50—Monitoring users, programs or devices to maintain the integrity of platforms, e.g. of processors, firmware or operating systems
- G06F21/52—Monitoring users, programs or devices to maintain the integrity of platforms, e.g. of processors, firmware or operating systems during program execution, e.g. stack integrity ; Preventing unwanted data erasure; Buffer overflow
- G06F21/53—Monitoring users, programs or devices to maintain the integrity of platforms, e.g. of processors, firmware or operating systems during program execution, e.g. stack integrity ; Preventing unwanted data erasure; Buffer overflow by executing in a restricted environment, e.g. sandbox or secure virtual machine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/62—Protecting access to data via a platform, e.g. using keys or access control rules
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/60—Protecting data
- G06F21/62—Protecting access to data via a platform, e.g. using keys or access control rules
- G06F21/6218—Protecting access to data via a platform, e.g. using keys or access control rules to a system of files or objects, e.g. local or distributed file system or database
- G06F21/6245—Protecting personal data, e.g. for financial or medical purposes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F8/00—Arrangements for software engineering
- G06F8/30—Creation or generation of source code
- G06F8/36—Software reuse
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F8/00—Arrangements for software engineering
- G06F8/70—Software maintenance or management
- G06F8/71—Version control; Configuration management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for program control, e.g. control units
- G06F9/06—Arrangements for program control, e.g. control units using stored programs, i.e. using an internal store of processing equipment to receive or retain programs
- G06F9/44—Arrangements for executing specific programs
- G06F9/455—Emulation; Interpretation; Software simulation, e.g. virtualisation or emulation of application or operating system execution engines
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for program control, e.g. control units
- G06F9/06—Arrangements for program control, e.g. control units using stored programs, i.e. using an internal store of processing equipment to receive or retain programs
- G06F9/44—Arrangements for executing specific programs
- G06F9/455—Emulation; Interpretation; Software simulation, e.g. virtualisation or emulation of application or operating system execution engines
- G06F9/45533—Hypervisors; Virtual machine monitors
- G06F9/45558—Hypervisor-specific management and integration aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for program control, e.g. control units
- G06F9/06—Arrangements for program control, e.g. control units using stored programs, i.e. using an internal store of processing equipment to receive or retain programs
- G06F9/46—Multiprogramming arrangements
- G06F9/50—Allocation of resources, e.g. of the central processing unit [CPU]
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for program control, e.g. control units
- G06F9/06—Arrangements for program control, e.g. control units using stored programs, i.e. using an internal store of processing equipment to receive or retain programs
- G06F9/44—Arrangements for executing specific programs
- G06F9/455—Emulation; Interpretation; Software simulation, e.g. virtualisation or emulation of application or operating system execution engines
- G06F9/45533—Hypervisors; Virtual machine monitors
- G06F9/45558—Hypervisor-specific management and integration aspects
- G06F2009/45562—Creating, deleting, cloning virtual machine instances
Definitions
- the present invention relates to a software providing device, a software providing method, and a program.
- Patent Document 1 discloses an analyzer used in a clinical trial in which an anticancer drug is administered to a colorectal cancer patient.
- an object of the present invention is to provide software for analyzing data on oncogenes while ensuring security.
- the software providing device is a software providing device that provides software for processing data related to cancer genes, and the software operates on a virtual machine and executes data processing related to cancer genes.
- the software providing device includes a module and setting information for determining an operation when the software module executes the data processing, and the software providing device receives an instruction regarding providing the software to a predetermined user group.
- the software provided to the predetermined user group by instructing the information processing apparatus that stores the virtual machine template including the software to duplicate the virtual machine template. It has a generation unit for causing the information processing apparatus to generate a new virtual machine including the above.
- FIG. 1 is a diagram showing an example of a software providing system according to the present embodiment.
- the user terminal 10A-1 and the user terminal 10A-2 are terminals used by the user group A.
- the user terminal 10B-1 and the user terminal 10B-2 are terminals used by the user group B.
- a user terminal 10A-1, the user terminal 10A-2, the user terminal 10B-1 and the user terminal 10B-2 are not distinguished, they are referred to as a user terminal 10. Further, in the present embodiment, there is no limit to the number of user terminals 10.
- User group A and user group B mean groups of users belonging to organizations such as hospitals and research institutes, respectively.
- the users belonging to the user group A are doctors, nurses, laboratory technicians, and the like.
- the user group B is a research institution, the user belonging to the user group B is a researcher or the like.
- the administrator terminal 20 is a terminal used by an administrator or the like (hereinafter referred to as “software administrator”) who manages software (hereinafter referred to as “oncogene software”) that processes data related to oncogenes. ..
- the software administrator operates the administrator terminal 20 to provide the oncogene software to the user group.
- the server 30 is composed of one or a plurality of physical information processing devices, and can operate one or more virtual machines on the hypervisor.
- the server 30 may be an information processing device managed by a software administrator or the like or an organization to which the software administrator belongs, or is an information processing device provided by a cloud service operated by a third party other than the software administrator. There may be.
- Each virtual machine contains an OS (Operating System) and oncogene software. That is, the oncogene software is software that can be operated on the virtual machine on the server 30.
- Virtual machine A is a virtual machine provided for user group A. Further, the virtual machine B is a virtual machine provided for the user group B. A virtual machine is also called a virtual machine instance.
- the virtual machine template is the data that is the basis for creating a new virtual machine, and includes the OS and oncogene software.
- User group A manages clinical information about cancer and analyzes various data by using oncogene software running on virtual machine A.
- the user group B manages clinical information about cancer and analyzes various data by using the oncogene software running on the virtual machine B.
- Virtual machine A and virtual machine B each operate as an independent virtual computer. Therefore, the user group A cannot access the data used by the user group B. Similarly, the user group B cannot access the data used by the user group A.
- the software administrator When the software administrator provides the cancer gene software to an organization wishing to use the cancer gene software, the software administrator copies a virtual machine template using the administrator terminal 20 to create a new virtual machine (for example, virtual machine C). ) Is generated, and the settings for the new organization are set for the generated virtual machine. New organizations will be able to use oncogene software in a secure environment by accessing the new virtual machines that have been created.
- a virtual machine for example, virtual machine C.
- any information processing device such as a personal computer (PC), a notebook PC, a smartphone, or a tablet terminal can be used as long as it is an information processing device having a communication function.
- PC personal computer
- notebook PC notebook PC
- smartphone smartphone
- tablet terminal any information processing device having a communication function.
- FIG. 2 is a diagram showing a hardware configuration example of the user terminal 10, the administrator terminal 20, and the server 30.
- the user terminal 10, the administrator terminal 20, and the server 30 include a processor 11 such as a CPU (Central Processing Unit) and a GPU (Graphical processing unit), a memory, an HDD (Hard Disk Drive), and / or an SSD (Solid State Drive). It has a storage device 12, a communication IF (Interface) 13 for wired or wireless communication, an input device 14 for accepting input operations, and an output device 15 for outputting information.
- the input device 14 is, for example, a keyboard, a touch panel, a mouse and / or a microphone.
- the output device 15 is, for example, a display, a touch panel, and / or a speaker.
- FIG. 3 is a diagram showing an example of a functional block configuration of the administrator terminal 20.
- the administrator terminal 20 includes a reception unit 201, a generation unit 202, and a display unit 203.
- the reception unit 201, the generation unit 202, and the display unit 203 can be realized by the processor 11 of the administrator terminal 20 executing the program stored in the storage device 12.
- the program can be stored in a storage medium.
- the storage medium in which the program is stored may be a non-transitory computer readable medium.
- the non-temporary storage medium is not particularly limited, but may be, for example, a storage medium such as a USB memory or a CD-ROM.
- the reception unit 201 receives various instructions regarding the provision of oncogene software from the software administrator. For example, the reception unit 201 receives an instruction regarding providing the oncogene software to a predetermined user group.
- the generation unit 202 requests the server 30 (information processing device) that stores the template of the virtual machine to virtualize the virtual machine including the cancer gene software.
- the server 30 is made to generate a new virtual machine including the software provided to a predetermined user group.
- the display unit 203 displays a screen for the software administrator to manage the oncogene software on the display.
- FIG. 4 is a diagram showing an example of a functional block configuration of the server 30.
- the server 30 includes a storage unit 300, a reception unit 301, and an execution unit 302.
- the storage unit 300 can be realized by using the storage device 12 included in the server 30.
- the reception unit 301 and the execution unit 302 can be realized by the processor 11 of the server 30 executing the program stored in the storage device 12.
- the program can be stored in a storage medium.
- the storage medium in which the program is stored may be a non-temporary storage medium that can be read by a computer.
- the non-temporary storage medium is not particularly limited, but may be, for example, a storage medium such as a USB memory or a CD-ROM.
- the storage unit 300 stores a virtual machine template and a file for executing one or more virtual machines (virtual machine A, virtual machine B, etc.).
- the reception unit 301 receives various operations (virtual machine duplication instructions, etc.) from an external information processing device (for example, the administrator terminal 20).
- the execution unit 302 operates the virtual machine stored in the storage unit 300 on the hypervisor. In addition, the execution unit 302 performs processing such as creating a virtual machine, starting a virtual machine, and replicating a virtual machine.
- each functional block included in the administrator terminal 20 may be implemented on the server 30 instead of the administrator terminal 20.
- the administrator terminal 20 may be a general terminal provided with a Web browser.
- the server 30 may have a Web server function, and the Web browser provided in the administrator terminal 20 may display a screen (such as FIG. 6 described later) related to the operation of the virtual machine according to the present embodiment.
- the cancer gene software is a data processing module (software module) that executes data processing related to cancer genes, and setting information (for example, various processes) for determining the operation when the data processing module executes data processing related to cancer management. Executability setting, etc.) and are included.
- the oncogene software may further include a database (for example, a database for storing clinical information) for storing various data handled by the data processing module.
- the data processing related to oncogenes performed by the data processing module includes multiple data processing related to oncogenes. For example, a process of managing a donor (cancer patient), a process of managing clinical information on an oncogene obtained from a donor, a process of analyzing clinical information on an oncogene, and the like can be mentioned.
- the process of managing donors includes a process of displaying a donor list page, a process of displaying an individual donor page, and the like.
- On the donor list page it is possible to search and filter donors based on the type of cancer and clinical information obtained from the donor.
- the individual donor page displays a list of oncogene mutations, clusters the oncogene mutations to show which cluster each donor belongs to, and a Pathway map of the mutated oncogenes in each donor. It is possible to perform operations such as displaying above and displaying / registering / editing / deleting clinical information.
- the process of managing clinical information provided by the donor includes the process of importing / exporting clinical information.
- processing to analyze clinical information related to oncogenes for example, Mutation bridge analysis, Alteration frequency analysis, DNA subsystem type analysis, Oncoprint analysis, Pathway analysis, Gene map analysis, Mutation signature analysis, Survival plot analysis, Crosstable test analysis. And so on.
- Mutation bridge analysis Alteration frequency analysis
- DNA subsystem type analysis for example, DNA subsystem type analysis, Oncoprint analysis, Pathway analysis, Gene map analysis, Mutation signature analysis, Survival plot analysis, Crosstable test analysis.
- Gene map analysis Gene map analysis
- Mutation signature analysis for survival plot analysis.
- Crosstable test analysis are not limited to the clinical information of individual donors, but it is also possible to select an arbitrary donor group and perform the clinical information of the selected donor group.
- the setting information includes information for setting the execution enablement / disapproval for each data processing related to the oncogene for each user group, in addition to the information regarding the user group using the oncogene software.
- the data processing module reads the setting information at startup to determine whether or not each data processing can be executed. That is, the data processing module operates so as to execute data processing that is permitted to be executed by the setting information for a plurality of data processes, and not to execute data processing that is not permitted to be executed by the setting information.
- FIG. 5 is a diagram showing an example of setting information.
- the "user group ID” stores an ID for identifying a user group that uses the oncogene software.
- the “user group name” the name of the user group that uses the oncogene software is stored.
- the “login ID / password” initial values of an ID and a password for logging in to the oncogene software are set.
- the "executability / non-execution setting the feasibility / non-execution for each data processing related to the oncogene is stored.
- FIG. 6 is a diagram showing an example of a screen for managing oncogene software.
- the software administrator provides the oncogene software to a new user group who wishes to use the oncogene software
- the oncogene software is generated using the screen displayed on the administrator terminal 20.
- the input area N10 is an area for inputting the ID and name of the user group using the oncogene software, the initial login ID for logging in to the oncogene software, and the password.
- the input area N11 is an area for setting whether or not to execute the data processing related to the oncogene. Whether or not the execution is possible is determined, for example, by the content of the license agreement between the software administrator and the user group.
- the oncogene software to be provided to the user group is generated.
- FIG. 7 is a diagram for explaining a processing procedure when oncogene software is generated.
- the processing procedure shown in FIG. 7 is executed, for example, by pressing the button B10 on the screen shown in FIG.
- step S10 the reception unit 201 of the administrator terminal 20 receives an instruction from the software administrator regarding providing the oncogene software to the user group X (predetermined user group) via the screen shown in FIG.
- the instructions include information about the user group X (name, login ID, etc.) and instructions for permitting the user group X to perform each of the plurality of data processes related to the oncogene. ..
- the button B10 is pressed on the screen shown in FIG. 6, the process proceeds to the processing procedure of step S11.
- step S11 the generation unit 202 instructs the server 30 to duplicate the virtual machine template.
- the execution unit 302 of the server 30 Upon receiving the instruction, the execution unit 302 of the server 30 generates a new virtual machine to be used by the user group X by duplicating the virtual machine template including the oncogene software.
- the virtual machine template includes the OS and cancer gene software (data processing module, setting information and database) in addition to the virtual machine setting data (CPU type, memory size, disk size, communication speed, etc.). .. Dummy data may be stored in the setting information. Further, the database may be an empty database in which no record is stored. Since the generated new virtual machine is a duplicate of the virtual machine template, it will include the OS and cancer gene software (data processing module, setting information and database) as in the virtual machine template.
- step S12 the generation unit 202 of the administrator terminal 20 manages the setting information included in the new virtual machine provided to the user group X generated by duplicating the virtual machine template by software in the processing procedure of step S10. It is set whether or not each of the plurality of data processes related to the oncogene for the user group X, which is instructed by the user, can be executed.
- the generation unit 202 may rewrite the setting information by directly manipulating the files constituting the new virtual machine before executing the new virtual machine.
- the generation unit 202 may start a new virtual machine, log in to the OS started on the new virtual machine, and then rewrite the setting information stored in the disk of the virtual machine.
- step S12 the software administrator informs the user group X of the initial login ID and password set in the setting information.
- a user belonging to the user group X can use the oncogene software by accessing the newly created virtual machine using the user terminal 10.
- the oncogene software is provided to a new user by duplicating the virtual machine template prepared in advance.
- the virtual machines created by duplicating the virtual machine template cannot communicate with each other and cannot refer to the data on other virtual machines because each operates as a different computer. Therefore, according to the present embodiment, it is possible to provide software for analyzing data related to cancer while ensuring security.
Landscapes
- Engineering & Computer Science (AREA)
- Software Systems (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Computer Security & Cryptography (AREA)
- Computer Hardware Design (AREA)
- General Health & Medical Sciences (AREA)
- Bioethics (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Databases & Information Systems (AREA)
- Stored Programmes (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
図1は、本実施形態に係るソフトウェア提供システムの一例を示す図である。ユーザ端末10A-1及びユーザ端末10A-2は、ユーザグループAが利用する端末である。ユーザ端末10B-1及びユーザ端末10B-2は、ユーザグループBが利用する端末である。以下、ユーザ端末10A-1、ユーザ端末10A-2、ユーザ端末10B-1及びユーザ端末10B-2を区別しない場合、ユーザ端末10と呼ぶ。また、本実施形態において、ユーザ端末10の台数に制限はない。
図2は、ユーザ端末10、管理者端末20及びサーバ30のハードウェア構成例を示す図である。ユーザ端末10、管理者端末20及びサーバ30は、CPU(Central Processing Unit)、GPU(Graphical processing unit)等のプロセッサ11、メモリ、HDD(Hard Disk Drive)及び/又はSSD(Solid State Drive)等の記憶装置12、有線又は無線通信を行う通信IF(Interface)13、入力操作を受け付ける入力デバイス14、及び情報の出力を行う出力デバイス15を有する。入力デバイス14は、例えば、キーボード、タッチパネル、マウス及び/又はマイク等である。出力デバイス15は、例えば、ディスプレイ、タッチパネル及び/又はスピーカ等である。
図3は、管理者端末20の機能ブロック構成例を示す図である。管理者端末20は、受付部201と、生成部202と、表示部203とを含む。受付部201と、生成部202と、表示部203とは、管理者端末20のプロセッサ11が、記憶装置12に記憶されたプログラムを実行することにより実現することができる。また、当該プログラムは、記憶媒体に格納することができる。当該プログラムを格納した記憶媒体は、コンピュータ読み取り可能な非一時的な記憶媒体(Non-transitory computer readable medium)であってもよい。非一時的な記憶媒体は特に限定されないが、例えば、USBメモリ又はCD-ROM等の記憶媒体であってもよい。
続いて、本実施形態に係るソフトウェア提供システムが行う処理内容を具体的に説明する。
以上説明した実施形態によれば、予め用意された仮想マシンテンプレートを複製することで、新たなユーザに癌遺伝子ソフトウェアを提供するようにした。仮想マシンテンプレートを複製することで生成された仮想マシンは、各々が異なるコンピュータとして動作することから、互いに通信をすることができず、また、他の仮想マシン上のデータを参照することもできない。従って、本実施形態によれば、癌に関するデータ解析を行うソフトウェアを、セキュリティを担保しながら提供することが可能になる。
Claims (6)
- 癌遺伝子に関するデータ処理を行うソフトウェアを提供するソフトウェア提供装置であって、
前記ソフトウェアは、仮想マシン上で動作し、癌遺伝子に関するデータ処理を実行するソフトウェアモジュールと、前記ソフトウェアモジュールが前記データ処理を実行する際の動作を決定するための設定情報とを含み、
前記ソフトウェア提供装置は、
前記ソフトウェアを、所定のユーザグループに提供することに関する指示を受け付ける受付部と、
前記指示を受け付けた場合、前記ソフトウェアを含む仮想マシンのテンプレートを記憶する情報処理装置に対して、前記仮想マシンのテンプレートの複製を指示することで、前記所定のユーザグループに提供するソフトウェアを含む新たな仮想マシンを、前記情報処理装置に生成させる生成部と、
を有するソフトウェア提供装置。 - 前記データ処理には、複数のデータ処理が含まれており、
前記設定情報には、前記複数のデータ処理の各々についての実行可否をユーザグループごとに設定するための情報が含まれており、
前記ソフトウェアモジュールは、前記複数のデータ処理について、前記設定情報により実行が許可されたデータ処理を実行し、前記設定情報により実行が許可されていないデータ処理については実行しないように動作する、
請求項1に記載のソフトウェア提供装置。 - 前記受付部が受け付ける前記指示には、前記所定のユーザグループに対し、前記複数のデータ処理の各々について実行を許可するか否かの指示が含まれており、
前記生成部は、前記新たな仮想マシンに含まれる前記設定情報に、前記指示された、前記所定のユーザグループに対する前記複数のデータ処理の各々についての実行可否を設定する、
請求項2に記載のソフトウェア提供装置。 - 前記データ処理は、癌遺伝子に関する臨床情報を解析する処理を含む、
請求項1~3のいずれか一項に記載のソフトウェア提供装置。 - 癌遺伝子に関するデータ処理を行うソフトウェアを提供するソフトウェア提供装置が実行するソフトウェア提供方法であって、
前記ソフトウェアは、仮想マシン上で動作し、癌遺伝子に関するデータ処理を実行するソフトウェアモジュールと、前記ソフトウェアモジュールが前記データ処理を実行する際の動作を決定するための設定情報とを含み、
前記ソフトウェア提供方法は、
前記ソフトウェアを、所定のユーザグループに提供することに関する指示を受け付けるステップと、
前記指示を受け付けた場合、前記ソフトウェアを含む仮想マシンのテンプレートを記憶する情報処理装置に対して、前記仮想マシンのテンプレートの複製を指示することで、前記所定のユーザグループに提供するソフトウェアを含む新たな仮想マシンを、前記情報処理装置に生成させるステップと、
を含むソフトウェア提供方法。 - 癌遺伝子に関するデータ処理を行うソフトウェアを提供するコンピュータに実行させるためのプログラムであって、
前記ソフトウェアは、仮想マシン上で動作し、癌遺伝子に関するデータ処理を実行するソフトウェアモジュールと、前記ソフトウェアモジュールが前記データ処理を実行する際の動作を決定するための設定情報とを含み、
前記コンピュータに、
前記ソフトウェアを、所定のユーザグループに提供することに関する指示を受け付けるステップと、
前記指示を受け付けた場合、前記ソフトウェアを含む仮想マシンのテンプレートを記憶する情報処理装置に対して、前記仮想マシンのテンプレートの複製を指示することで、前記所定のユーザグループに提供するソフトウェアを含む新たな仮想マシンを、前記情報処理装置に生成させるステップと、
を実行させるためのプログラム。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180068770.8A CN116324722A (zh) | 2020-10-07 | 2021-10-07 | 软件提供装置、软件提供方法及程序 |
EP21877719.1A EP4227833A1 (en) | 2020-10-07 | 2021-10-07 | Software providing device, software providing method, and program |
US18/030,612 US20230367621A1 (en) | 2020-10-07 | 2021-10-07 | Software providing apparatus, software providing method, and program |
JP2022555568A JPWO2022075420A1 (ja) | 2020-10-07 | 2021-10-07 | |
KR1020237014722A KR20230084523A (ko) | 2020-10-07 | 2021-10-07 | 소프트웨어 제공 장치, 소프트웨어 제공 방법 및 프로그램 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020169809 | 2020-10-07 | ||
JP2020-169809 | 2020-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022075420A1 true WO2022075420A1 (ja) | 2022-04-14 |
Family
ID=81126980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/037205 WO2022075420A1 (ja) | 2020-10-07 | 2021-10-07 | ソフトウェア提供装置、ソフトウェア提供方法及びプログラム |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230367621A1 (ja) |
EP (1) | EP4227833A1 (ja) |
JP (1) | JPWO2022075420A1 (ja) |
KR (1) | KR20230084523A (ja) |
CN (1) | CN116324722A (ja) |
WO (1) | WO2022075420A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019503016A (ja) * | 2015-10-26 | 2019-01-31 | サイフェローム | がん患者のゲノム塩基配列変異情報と生存情報を利用したカスタマイズ型の薬物選択方法及びシステム |
JP2019049798A (ja) * | 2017-09-08 | 2019-03-28 | アビームコンサルティング株式会社 | 移送方法 |
JP2019091153A (ja) * | 2017-11-13 | 2019-06-13 | 富士通株式会社 | 管理プログラム、管理装置および管理方法 |
JP2020071517A (ja) | 2018-10-29 | 2020-05-07 | 株式会社日立製作所 | 分析装置、分析方法、および分析プログラム |
-
2021
- 2021-10-07 JP JP2022555568A patent/JPWO2022075420A1/ja active Pending
- 2021-10-07 EP EP21877719.1A patent/EP4227833A1/en active Pending
- 2021-10-07 KR KR1020237014722A patent/KR20230084523A/ko unknown
- 2021-10-07 CN CN202180068770.8A patent/CN116324722A/zh active Pending
- 2021-10-07 US US18/030,612 patent/US20230367621A1/en active Pending
- 2021-10-07 WO PCT/JP2021/037205 patent/WO2022075420A1/ja unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019503016A (ja) * | 2015-10-26 | 2019-01-31 | サイフェローム | がん患者のゲノム塩基配列変異情報と生存情報を利用したカスタマイズ型の薬物選択方法及びシステム |
JP2019049798A (ja) * | 2017-09-08 | 2019-03-28 | アビームコンサルティング株式会社 | 移送方法 |
JP2019091153A (ja) * | 2017-11-13 | 2019-06-13 | 富士通株式会社 | 管理プログラム、管理装置および管理方法 |
JP2020071517A (ja) | 2018-10-29 | 2020-05-07 | 株式会社日立製作所 | 分析装置、分析方法、および分析プログラム |
Also Published As
Publication number | Publication date |
---|---|
JPWO2022075420A1 (ja) | 2022-04-14 |
EP4227833A1 (en) | 2023-08-16 |
US20230367621A1 (en) | 2023-11-16 |
CN116324722A (zh) | 2023-06-23 |
KR20230084523A (ko) | 2023-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pai et al. | Standard electronic health record (EHR) framework for Indian healthcare system | |
Mamlin et al. | The promise of information and communication technology in healthcare: extracting value from the chaos | |
US10083064B2 (en) | Systems and methods for smart tools in sequence pipelines | |
JP2020098634A (ja) | 統合された臨床ケアのための情報科学プラットフォーム | |
US20130212061A1 (en) | Content analytics system configured to support multiple tenants | |
CN112257108B (zh) | 数据脱敏方法及装置、介质及电子设备 | |
US20150066381A1 (en) | Genomic pipeline editor with tool localization | |
JP2018508845A (ja) | ノートブックアプリケーションでのクラスノートブックおよびそのセクショングループへのアクセス許可の管理 | |
Bradford et al. | Development of a HIPAA-compliant environment for translational research data and analytics | |
Nalluri et al. | MACHINE LEARNING AND IMMERSIVE TECHNOLOGIES FOR USER-CENTERED DIGITAL HEALTHCARE INNOVATION | |
CN111128325A (zh) | 医疗数据存储方法及装置、电子设备和存储介质 | |
US20210295956A1 (en) | Systems and Methods for Hashing-Based Assessment of Electronic Clinical Trial Outcomes | |
EP3144831A1 (en) | Information processing apparatus, information processing method, and program | |
WO2022075420A1 (ja) | ソフトウェア提供装置、ソフトウェア提供方法及びプログラム | |
JP2020035066A (ja) | 情報秘匿化方法、情報秘匿化プログラム、情報秘匿化装置および情報提供システム | |
CN114360671A (zh) | 电子病历的生成方法和装置、存储介质和电子装置 | |
US20090150438A1 (en) | Export file format with manifest for enhanced data transfer | |
Ye et al. | Design and implementation of a mobile system for lung cancer patient follow-up in China and initial report of the ongoing patient registry | |
Koh et al. | STAGEs: A web-based tool that integrates data visualization and pathway enrichment analysis for gene expression studies | |
Argraves et al. | ArrayQuest: a web resource for the analysis of DNA microarray data | |
JP6799775B2 (ja) | サーバ装置、通信システム、情報処理方法、および、情報処理プログラム | |
JP6858603B2 (ja) | 傷病名変更情報出力プログラム、傷病名変更情報出力システム、および、傷病名変更情報出力方法 | |
Daniyan | pyGROMODS: a Python package for the generation of input files for molecular dynamic simulation with GROMACS | |
US20130246095A1 (en) | Method and system for producing automated medical reports | |
O'Mahony et al. | Tablet computers for recording tuberculosis data at a community health centre in King Sabata Dalindyebo Local Municipality, Eastern Cape: a proof of concept report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21877719 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022555568 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20237014722 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021877719 Country of ref document: EP Effective date: 20230508 |